"I am really trying to change the traditional CFO landscape," said Mr. Firdausi during an interview with "Becker's Healthcare Podcast." "Having the PBM background, having the payer background and now ...

PBMs interface with pharmacies and the payers. In addition to adjudicating pharmacy charges, the PBM provides the payer with access to a nationwide network of pharmacy providers that are ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

The leadership of the Senate Committee on Health, Education, Labor and Pensions (HELP) listed some key retirement and health priorities for the Committee for this session of Congress, during a hearing ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...

Americans have grown used to employer-sponsored care. But it’s a significant contributor to the system’s maddening costs and complexities. The sooner lawmakers accept this fact, the sooner the country ...

The idea of a government-run, single payer healthcare system While centralising ... would be huge resistance from hospitals, HCPs, pharmacy benefit managers and other care providers that are ...

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...

Number 2: Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar competition, according to Samsung Bioepis’ most recent market report, ...

The middlemen that comprise a growing share of America’s convoluted health care system find themselves in a bind.

The middlemen who comprise a growing share of America’s convoluted health care system find themselves in a bind. The public is angry about the inflated costs and opaque dealings that govern their ...

In 2025, the three largest pharmacy benefit managers are largely rejecting biosimilars from their formularies, with the exception of their own private-label medicines, Drug Channels reported Jan. 22.